Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness
Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment
Clinical Scorecard: Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness
At a Glance
| Category | Detail |
|---|
| Condition | Pandemic-prone viral infections |
| Key Mechanisms | Molecular fingerprinting of biological samples using Raman spectroscopy and its enhanced variants. |
| Target Population | Individuals at risk of viral infections, including those with influenza, SARS-CoV-2, Ebola, and dengue. |
| Care Setting | Clinical diagnostics and virology research. |
Key Highlights
- Raman spectroscopy offers rapid, label-free insight into viruses and host responses.
- Enhanced techniques like SERS, TERS, and CARS improve sensitivity and resolution.
- Raman-based methods show rapid detection capabilities for influenza and SARS-CoV-2.
- Research focus is skewed towards high-impact viruses, neglecting high-risk pathogens.
- Technical barriers such as weak signal intensity and fluorescence interference hinder clinical translation.
Guideline-Based Recommendations
Diagnosis
- Utilize Raman spectroscopy for rapid identification of viral particles in biological samples.
Management
- Incorporate enhanced Raman techniques for improved detection and monitoring of viral infections.
Monitoring & Follow-up
- Regularly assess the performance of Raman-based diagnostics in clinical settings.
Risks
- Address technical challenges including weak signal intensity and regulatory hurdles.
Patient & Prescribing Data
Individuals suspected of having viral infections.
Raman spectroscopy can facilitate timely diagnosis and management of viral infections.
Clinical Best Practices
- Implement standardized protocols for Raman spectroscopy to enhance reproducibility.
- Explore AI-driven analysis to improve diagnostic accuracy and efficiency.
- Focus research efforts on underexplored high-risk pathogens to broaden diagnostic capabilities.
References
